ZAP Surgical Systems welcomes Stanley Lu to its Board of Directors

– USA, CA –  ZAP Surgical Systems, Inc., developer and manufacturer of the ZAP-X surgical robot for non-invasive ablation of brain tumors, today announced the appointment of Stanley Lu to its Board of Directors.

“I am thrilled to welcome Stanley Lu to our Board of Directors where he will join us in our common quest to treat and transform the lives of millions of patients each year by means of the ZAP-X surgical robot,” said CEO, Dr. John Adler. “At ZAP we have developed the next-generation platform for non-invasively treating brain cancer. Unfortunately, more than 4 million people each year suffer from brain, head & neck cancers and are not being treated optimally with existing radiosurgical solutions. ZAP’s singular goal is to meet this challenge.”

About Lu Jun-Fu (Stanley Lu)

Stanley Lu is the Chairman of Foxconn Technology Co Ltd, elected in October 2021. Stanley received an EMBA from the Chinese University of Hong Kong and an EMBA from the National Sun Yat-sen University. Prior, Stanley was CFO and spokesperson of Foxsemicon Integrated Technology Inc.

Terry Guo, founder, and former Chairman and CEO of Foxconn, co-founded ZAP Surgical in 2014 and contributed entrepreneurial expertise, and his anchor investment established ZAP Surgical as an independent company. Before the company’s inception, the ZAP-X platform was developed within and spun out from Varian Medical Systems, now a Siemens Healthineers company.

About ZAP Surgical Systems, Inc.

ZAP Surgical Systems, Inc. designs and manufactures the ZAP-X Gyroscopic Radiosurgery platform. ZAP was founded in 2014 by Dr. John R. Adler. In addition to being CEO of ZAP, Dr. Adler is Emeritus Dorothy & TK Chan Professor of Neurosurgery and Radiation Oncology at Stanford University. Dr. Adler is also renowned as the inventor of the CyberKnife system and founder of Accuray, Inc. The ZAP-X platform incorporates a unique vault-free design that typically eliminates the need for costly shielded treatment rooms. ZAP-X also utilizes a modern linear accelerator to eliminate the legacy use of Cobalt-60.

In addition to Foxconn and Siemens Healthineers, ZAP investors include Primavera Capital Group, Chow Tai Fook Enterprises, GT Healthcare Capital Partners, ShangBay Capital, and Hogy Medical.

For more information: https://zapsurgical.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.